Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion type Assertion NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_head.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion description "[The purpose is to study the prognostic significance of tissue expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor (TATI) and serum concentration of trypsinogen-2, trypsin-2-API (complex of trypsin-2 with alpha-1-proteinase inhibitor), and TATI in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion evidence source_evidence_literature NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion SIO_000772 15269150 NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion wasDerivedFrom befree-20140225 NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion wasGeneratedBy ECO_0000203 NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.